Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Management
Scientific Advisory Board
Corporate Directory
Corporate Governance
Pipeline
Amplia's Pipeline
Amplia's Cancer Program
Amplia's Fibrosis Program
Investor Information
Welcome
Investor Fact Sheet
Investor Presentation
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
30-Jun-2022
Application for quotation of securities - ATX
29-Jun-2022
Annual General Meeting to be held Thursday 25 August 2022
24-Jun-2022
Registered Office and Principal Place of Business
9-Jun-2022
Notification of Expiry of Unlisted Options
9-Jun-2022
Application for quotation of securities - ATX
2-Jun-2022
AMP945 Shows Efficacy in Model of Lung Fibrosis
30-May-2022
App 4G - Key to Corporate Governance Disclosures
30-May-2022
Corporate Governance Statement
30-May-2022
Preliminary Final Report and Annual Report YE 31 March 2022
13-May-2022
Amplia Receives Second Ethics Clearance for Phase 2 Trial
Previous
1
2
3
4
Next
